Serial analysis of biomarkers of acute pancreas allograft rejection

Clinical Transplantation

Volumn 24, Issue 6, 2010, Pages

  Cashion, A K ^a   Sabek, O ^b   Driscoll, C ^c   Gaber, L ^b   Tolley, E ^a   Gaber, A O ^b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Biomarkers; Pancreas allograft; Pancreas transplantation; Rejection

Indexed keywords

GRANZYME B; HLA DR ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PERFORIN; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GENE EXPRESSION; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; PANCREAS BIOPSY; PANCREAS TRANSPLANTATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; UPREGULATION;

ADULT; BIOLOGICAL MARKERS; FEMALE; GRAFT REJECTION; GRANZYMES; HLA-DR ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PANCREAS TRANSPLANTATION; PERFORIN; POLYMERASE CHAIN REACTION; TRANSPLANTATION, HOMOLOGOUS;

EID: 78649893451     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2010.01285.x     Document Type: Article

References (25)

1. Kaplan B, West-Thielke P, Herren H et al. Reported isolated pancreas rejection is associated with poor kidney outcomes in recipients of a simultaneous pancreas kidney transplant. Transplantation 2008: 86: 1229.
2. Knight RJ, Kerman RH, Podder H, Katz SM, Van Buren CT, Kahan BD. Graft survival and immune regulation of pancreas allograft recipients induced with thymoglobulin, sirolimus, and cyclosporine. Transplant Proc 2005: 37: 1280.
3. Odorico JS, Pirsch JD, Knechtle SJ, D'Alessandro AM, Sollinger HW. A study comparing mycophenolate mofetil to azathioprine in simultaneous pancreas-kidney transplantation. Transplantation 1998: 66: 1751.
4. Stratta RJ, Shokouh-Amiri MH, Egidi MF et al. Long-term experience with simultaneous kidney-pancreas transplantation with portal-enteric drainage and tacrolimus/mycophenolate mofetil-based immunosuppression. Clin Transplant 2003: 17(Suppl 9): 69.
5. Takahashi H, Kato T, Mizutani K et al. Simultaneous antibody-mediated rejection of multiple allografts in modified multivisceral transplantation. Clin Transplant 2006: 529.
6. Waki K, Kadowaki T. An analysis of long-term survival from the OPTN/UNOS Pancreas Transplant Registry. Clin Transplant 2007: 9.
7. Humar A, Kandaswamy R, Drangstveit MB, Parr E, Gruessner AG, Sutherland DE. Surgical risks and outcome of pancreas retransplants. Surgery 2000: 127: 634.
8. Cashion A, Sabek O, Driscoll C, Gaber L, Kotb M, Gaber O. Correlation of genetic markers of rejection with biopsy findings following human pancreas transplant. Clin Transplant 2006: 20: 106.
9. Oliverira SG, Genzini T, Perosa M et al. Analysis of the inflammatory infiltrate in pancreas allograft biopsies. Transplantation 2002: 74 (Suppl): 81.
10. Rush DN, Henry SF, Jeffery JR, Schroeder TJ, Gough J. Histological findings in early routine biopsies of stable renal allograft recipients. Transplantation 1994: 57: 208.
11. Seron D, Moreso F. Protocol biopsies in renal transplantation: prognostic value of structural monitoring. Kidney Int 2007: 72: 690.
12. Simon T, Opelz G, Wiesel M, Ott RC, Susal C. Serial peripheral blood perforin and granzyme B gene expression measurements for prediction of acute rejection in kidney graft recipients. Am J Transplant 2003: 3: 1121.
13. Drachenberg C, Klassen D, Bartlett S et al. Histologic grading of pancreas acute allograft rejection in percutaneous needle biopsies. Transplant Proc 1996: 28: 512.
14. Drachenberg CB, Odorico J, Demetris AJ et al. Banff schema for grading pancreas allograft rejection: working proposal by a multi-disciplinary international consensus panel. Am J Transplant 2008: 8: 1237.
15. Han D, Xu X, Baidal D et al. Assessment of cytotoxic lymphocyte gene expression in the peripheral blood of human islet allograft recipients: elevation precedes clinical evidence of rejection. Diabetes 2004: 53: 2281.
16. Li B, Hartono C, Ding R et al. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N Engl J Med 2001: 344: 947.
17. Sabek O, Dorak MT, Kotb M, Gaber AO, Gaber L. Quantitative detection of T-cell activation markers by real-time PCR in renal transplant rejection and correlation with histopathologic evaluation. Transplantation 2002: 74: 701.
18. Shoker A, George D, Yang H, Baltzan M. Heightened CD40 ligand gene expression in peripheral CD4 + T cells from patients with kidney allograft rejection. Transplantation 2000: 70: 497.
19. Vasconcellos LM, Schachter AD, Zheng XX et al. Cytotoxic lymphocyte gene expression in peripheral blood leukocytes correlates with rejecting renal allografts. Transplantation 1998: 66: 562.
20. Yannaraki M, Rebibou JM, Ducloux D et al. Urinary cytotoxic molecular markers for a noninvasive diagnosis in acute renal transplant rejection. Transpl Int 2006: 19: 759.
21. Schulz M, Schuurman HJ, Joergensen J et al. Acute rejection of vascular heart allografts by perforin-deficient mice. Eur J Immunol 1995: 25: 474.
22. Heusel JW, Wesselschmidt RL, Shresta S, Russell JH, Ley TJ. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 1994: 76: 977.
23. Fang KC. Clinical utilities of peripheral blood gene expression profiling in the management of cardiac transplant patients. J Immunotoxicol 2007: 4: 209.
24. Yamani MH, Taylor DO, Haire C, Smedira N, Starling RC. Post-transplant ischemic injury is associated with up-regulated AlloMap gene expression. Clin Transplant 2007: 21: 523.
25. Yamani MH, Taylor DO, Rodriguez ER et al. Transplant vasculopathy is associated with increased AlloMap gene expression score. J Heart Lung Transplant 2007: 26: 403.